A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms

High lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for cardiovascular outcomes. Concentrations are strongly influenced by apo(a) kringle IV repeat isoforms. We aimed to identify genetic loci associated with Lp(a) concentrations using data from five genome-wide association stu...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of lipid research Ročník 58; číslo 9; s. 1834 - 1844
Hlavní autori: Mack, Salome, Coassin, Stefan, Rueedi, Rico, Yousri, Noha A, Seppälä, Ilkka, Gieger, Christian, Schönherr, Sebastian, Forer, Lukas, Erhart, Gertraud, Marques-Vidal, Pedro, Ried, Janina S, Waeber, Gerard, Bergmann, Sven, Dähnhardt, Doreen, Stöckl, Andrea, Raitakari, Olli T, Kähönen, Mika, Peters, Annette, Meitinger, Thomas, Strauch, Konstantin, Kedenko, Ludmilla, Paulweber, Bernhard, Lehtimäki, Terho, Hunt, Steven C, Vollenweider, Peter, Lamina, Claudia, Kronenberg, Florian
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Elsevier 01.09.2017
Predmet:
ISSN:1539-7262, 0022-2275, 1539-7262
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract High lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for cardiovascular outcomes. Concentrations are strongly influenced by apo(a) kringle IV repeat isoforms. We aimed to identify genetic loci associated with Lp(a) concentrations using data from five genome-wide association studies (n = 13,781). We identified 48 independent SNPs in the and 1 SNP in the gene region to be significantly associated with Lp(a) concentrations. We also adjusted for apo(a) isoforms to identify loci affecting Lp(a) levels independently from them, which resulted in 31 SNPs (30 in the , 1 in the gene region). Seven SNPs showed a genome-wide significant association with coronary artery disease (CAD) risk. A rare SNP (rs186696265; MAF ∼1%) showed the highest effect on Lp(a) and was also associated with increased risk of CAD (odds ratio = 1.73, = 3.35 × 10 ). Median Lp(a) values increased from 2.1 to 91.1 mg/dl with increasing number of Lp(a)-increasing alleles. We found the -determining allele of rs7412 to be significantly associated with Lp(a) concentrations ( = 3.47 × 10 ). Each allele decreased Lp(a) by 3.34 mg/dl corresponding to ∼15% of the population's mean values. Performing a gene-based test of association, including suspected Lp(a) receptors and regulators, resulted in one significant association of the gene with Lp(a) ( = 3.4 × 10 ). In summary, we identified a large number of independent SNPs in the gene region, as well as the allele, to be significantly associated with Lp(a) concentrations.
AbstractList High lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for cardiovascular outcomes. Concentrations are strongly influenced by apo(a) kringle IV repeat isoforms. We aimed to identify genetic loci associated with Lp(a) concentrations using data from five genome-wide association studies (n = 13,781). We identified 48 independent SNPs in the and 1 SNP in the gene region to be significantly associated with Lp(a) concentrations. We also adjusted for apo(a) isoforms to identify loci affecting Lp(a) levels independently from them, which resulted in 31 SNPs (30 in the , 1 in the gene region). Seven SNPs showed a genome-wide significant association with coronary artery disease (CAD) risk. A rare SNP (rs186696265; MAF ∼1%) showed the highest effect on Lp(a) and was also associated with increased risk of CAD (odds ratio = 1.73, = 3.35 × 10 ). Median Lp(a) values increased from 2.1 to 91.1 mg/dl with increasing number of Lp(a)-increasing alleles. We found the -determining allele of rs7412 to be significantly associated with Lp(a) concentrations ( = 3.47 × 10 ). Each allele decreased Lp(a) by 3.34 mg/dl corresponding to ∼15% of the population's mean values. Performing a gene-based test of association, including suspected Lp(a) receptors and regulators, resulted in one significant association of the gene with Lp(a) ( = 3.4 × 10 ). In summary, we identified a large number of independent SNPs in the gene region, as well as the allele, to be significantly associated with Lp(a) concentrations.
High lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for cardiovascular outcomes. Concentrations are strongly influenced by apo(a) kringle IV repeat isoforms. We aimed to identify genetic loci associated with Lp(a) concentrations using data from five genome-wide association studies (n = 13,781). We identified 48 independent SNPs in the LPA and 1 SNP in the APOE gene region to be significantly associated with Lp(a) concentrations. We also adjusted for apo(a) isoforms to identify loci affecting Lp(a) levels independently from them, which resulted in 31 SNPs (30 in the LPA, 1 in the APOE gene region). Seven SNPs showed a genome-wide significant association with coronary artery disease (CAD) risk. A rare SNP (rs186696265; MAF ∼1%) showed the highest effect on Lp(a) and was also associated with increased risk of CAD (odds ratio = 1.73, P = 3.35 × 10-30). Median Lp(a) values increased from 2.1 to 91.1 mg/dl with increasing number of Lp(a)-increasing alleles. We found the APOE2-determining allele of rs7412 to be significantly associated with Lp(a) concentrations (P = 3.47 × 10-10). Each APOE2 allele decreased Lp(a) by 3.34 mg/dl corresponding to ∼15% of the population's mean values. Performing a gene-based test of association, including suspected Lp(a) receptors and regulators, resulted in one significant association of the TLR2 gene with Lp(a) (P = 3.4 × 10-4). In summary, we identified a large number of independent SNPs in the LPA gene region, as well as the APOE2 allele, to be significantly associated with Lp(a) concentrations.High lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for cardiovascular outcomes. Concentrations are strongly influenced by apo(a) kringle IV repeat isoforms. We aimed to identify genetic loci associated with Lp(a) concentrations using data from five genome-wide association studies (n = 13,781). We identified 48 independent SNPs in the LPA and 1 SNP in the APOE gene region to be significantly associated with Lp(a) concentrations. We also adjusted for apo(a) isoforms to identify loci affecting Lp(a) levels independently from them, which resulted in 31 SNPs (30 in the LPA, 1 in the APOE gene region). Seven SNPs showed a genome-wide significant association with coronary artery disease (CAD) risk. A rare SNP (rs186696265; MAF ∼1%) showed the highest effect on Lp(a) and was also associated with increased risk of CAD (odds ratio = 1.73, P = 3.35 × 10-30). Median Lp(a) values increased from 2.1 to 91.1 mg/dl with increasing number of Lp(a)-increasing alleles. We found the APOE2-determining allele of rs7412 to be significantly associated with Lp(a) concentrations (P = 3.47 × 10-10). Each APOE2 allele decreased Lp(a) by 3.34 mg/dl corresponding to ∼15% of the population's mean values. Performing a gene-based test of association, including suspected Lp(a) receptors and regulators, resulted in one significant association of the TLR2 gene with Lp(a) (P = 3.4 × 10-4). In summary, we identified a large number of independent SNPs in the LPA gene region, as well as the APOE2 allele, to be significantly associated with Lp(a) concentrations.
High lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for cardiovascular outcomes. Concentrations are strongly influenced by apo(a) kringle IV repeat isoforms. We aimed to identify genetic loci associated with Lp(a) concentrations using data from five genome-wide association studies (n = 13,781). We identified 48 independent SNPs in the LPA and 1 SNP in the APOE gene region to be significantly associated with Lp(a) concentrations. We also adjusted for apo(a) isoforms to identify loci affecting Lp(a) levels independently from them, which resulted in 31 SNPs (30 in the LPA, 1 in the APOE gene region). Seven SNPs showed a genome-wide significant association with coronary artery disease (CAD) risk. A rare SNP (rs186696265; MAF ∼1%) showed the highest effect on Lp(a) and was also associated with increased risk of CAD (odds ratio = 1.73, P = 3.35 × 10−30). Median Lp(a) values increased from 2.1 to 91.1 mg/dl with increasing number of Lp(a)-increasing alleles. We found the APOE2-determining allele of rs7412 to be significantly associated with Lp(a) concentrations (P = 3.47 × 10−10). Each APOE2 allele decreased Lp(a) by 3.34 mg/dl corresponding to ∼15% of the populationʼns mean values. Performing a gene-based test of association, including suspected Lp(a) receptors and regulators, resulted in one significant association of the TLR2 gene with Lp(a) (P = 3.4 × 10−4). In summary, we identified a large number of independent SNPs in the LPA gene region, as well as the APOE2 allele, to be significantly associated with Lp(a) concentrations.
Author Forer, Lukas
Yousri, Noha A
Waeber, Gerard
Ried, Janina S
Kähönen, Mika
Paulweber, Bernhard
Meitinger, Thomas
Marques-Vidal, Pedro
Seppälä, Ilkka
Schönherr, Sebastian
Stöckl, Andrea
Dähnhardt, Doreen
Gieger, Christian
Coassin, Stefan
Erhart, Gertraud
Kronenberg, Florian
Mack, Salome
Kedenko, Ludmilla
Hunt, Steven C
Lamina, Claudia
Peters, Annette
Bergmann, Sven
Lehtimäki, Terho
Vollenweider, Peter
Rueedi, Rico
Raitakari, Olli T
Strauch, Konstantin
Author_xml – sequence: 1
  givenname: Salome
  surname: Mack
  fullname: Mack, Salome
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria
– sequence: 2
  givenname: Stefan
  surname: Coassin
  fullname: Coassin, Stefan
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria
– sequence: 3
  givenname: Rico
  surname: Rueedi
  fullname: Rueedi, Rico
  organization: Department of Computational Biology, University of Lausanne, 1015 Lausanne, Switzerland; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland
– sequence: 4
  givenname: Noha A
  surname: Yousri
  fullname: Yousri, Noha A
  organization: Department of Physiology and Biophysics, Weill Cornell Medical College-Qatar, Doha, Qatar; Department of Computer and Systems Engineering, Alexandria University, 21526 Alexandria, Egypt
– sequence: 5
  givenname: Ilkka
  surname: Seppälä
  fullname: Seppälä, Ilkka
  organization: Department of Clinical Chemistry, Fimlab Laboratories and University of Tampere School of Medicine, 33520 Tampere, Finland
– sequence: 6
  givenname: Christian
  surname: Gieger
  fullname: Gieger, Christian
  organization: Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany; Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany
– sequence: 7
  givenname: Sebastian
  surname: Schönherr
  fullname: Schönherr, Sebastian
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria
– sequence: 8
  givenname: Lukas
  surname: Forer
  fullname: Forer, Lukas
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria
– sequence: 9
  givenname: Gertraud
  surname: Erhart
  fullname: Erhart, Gertraud
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria
– sequence: 10
  givenname: Pedro
  surname: Marques-Vidal
  fullname: Marques-Vidal, Pedro
  organization: Department of Medicine, Internal Medicine, Lausanne University Hospital, 1015 Lausanne, Switzerland
– sequence: 11
  givenname: Janina S
  surname: Ried
  fullname: Ried, Janina S
  organization: Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany
– sequence: 12
  givenname: Gerard
  surname: Waeber
  fullname: Waeber, Gerard
  organization: Department of Medicine, Internal Medicine, Lausanne University Hospital, 1015 Lausanne, Switzerland
– sequence: 13
  givenname: Sven
  surname: Bergmann
  fullname: Bergmann, Sven
  organization: Department of Computational Biology, University of Lausanne, 1015 Lausanne, Switzerland; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland
– sequence: 14
  givenname: Doreen
  surname: Dähnhardt
  fullname: Dähnhardt, Doreen
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria
– sequence: 15
  givenname: Andrea
  surname: Stöckl
  fullname: Stöckl, Andrea
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria
– sequence: 16
  givenname: Olli T
  surname: Raitakari
  fullname: Raitakari, Olli T
  organization: Department of Clinical Physiology, Turku University Hospital, 20520 Turku, Finland; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, 20520 Turku, Finland
– sequence: 17
  givenname: Mika
  surname: Kähönen
  fullname: Kähönen, Mika
  organization: Department of Clinical Physiology, Tampere University Hospital and University of Tampere, 33521 Tampere, Finland
– sequence: 18
  givenname: Annette
  surname: Peters
  fullname: Peters, Annette
  organization: Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany; German Centre for Cardiovascular Research (DZHK), 80802 Munich, Germany; German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany
– sequence: 19
  givenname: Thomas
  surname: Meitinger
  fullname: Meitinger, Thomas
  organization: Institute of Human Genetics, Technische Universität München, 81675 München, Germany; Institute of Human Genetics, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
– sequence: 20
  givenname: Konstantin
  surname: Strauch
  fullname: Strauch, Konstantin
  organization: Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany; Institute of Medical Informatics, Biometry, and Epidemiology, Ludwig-Maximilians-Universität, 81377 Munich, Germany
– sequence: 21
  givenname: Ludmilla
  surname: Kedenko
  fullname: Kedenko, Ludmilla
  organization: First Department of Internal Medicine, Paracelsus Private Medical University, 5020 Salzburg, Austria
– sequence: 22
  givenname: Bernhard
  surname: Paulweber
  fullname: Paulweber, Bernhard
  organization: First Department of Internal Medicine, Paracelsus Private Medical University, 5020 Salzburg, Austria
– sequence: 23
  givenname: Terho
  surname: Lehtimäki
  fullname: Lehtimäki, Terho
  organization: Department of Clinical Chemistry, Fimlab Laboratories and University of Tampere School of Medicine, 33520 Tampere, Finland
– sequence: 24
  givenname: Steven C
  surname: Hunt
  fullname: Hunt, Steven C
  organization: Cardiovascular Genetics Division, University of Utah School of Medicine, Salt Lake City, UT 84108; Department of Genetic Medicine, Weill Cornell Medicine, Doha, Qatar
– sequence: 25
  givenname: Peter
  surname: Vollenweider
  fullname: Vollenweider, Peter
  organization: Department of Medicine, Internal Medicine, Lausanne University Hospital, 1015 Lausanne, Switzerland
– sequence: 26
  givenname: Claudia
  surname: Lamina
  fullname: Lamina, Claudia
  email: Claudia.Lamina@i-med.ac.at
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria. Electronic address: Claudia.Lamina@i-med.ac.at
– sequence: 27
  givenname: Florian
  surname: Kronenberg
  fullname: Kronenberg, Florian
  email: Florian.Kronenberg@i-med.ac.at
  organization: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, 6020 Innsbruck, Austria. Electronic address: Florian.Kronenberg@i-med.ac.at
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28512139$$D View this record in MEDLINE/PubMed
BookMark eNpdkMtLxDAQxoMo7vo4eZcc10PX5tGmPcriY0HxoucyTSaSpU3WpEX2v7esD0TmMMM3P755nJBDHzwScsHyJWO1vN50cfmUq5ILfkDmrBB1pnjJD__UM3KS0ibPmZQlOyYzXhWMM1HPSbyhb-hDj9mHM0ghpaAdDC542uMAGXjodsklOgmd24ZtDAM6TxdwRXXwGv0Q93iiYDZjGtBQGyKFbfiPuxSmTp_OyJGFLuH5dz4lr3e3L6uH7PH5fr26ecx0wdmQtVWhhUFA3molmQJk1VSCErWqwQpprMoFVJUWWFqGFbZWF1KKXGgsGYhTsv7yNQE2zTa6HuKuCeCavRDiWwNxcLrDRk5GyK2ypjRyCrDK1G0OCKUqgYvJa_HlNR30PmIamt4ljV0HHsOYGlbV01ai3qOX3-jY9mh-B__8XHwCQ-yHdQ
CitedBy_id crossref_primary_10_1161_ATVBAHA_120_314965
crossref_primary_10_1097_MOL_0000000000000981
crossref_primary_10_1007_s11883_024_01187_6
crossref_primary_10_1080_07853890_2018_1498118
crossref_primary_10_1161_ATVBAHA_119_313226
crossref_primary_10_1186_s13073_024_01391_8
crossref_primary_10_1016_j_ajhg_2021_11_005
crossref_primary_10_1016_j_gene_2018_06_097
crossref_primary_10_1093_cvr_cvab247
crossref_primary_10_1161_JAHA_124_038608
crossref_primary_10_1016_j_amjcard_2025_02_034
crossref_primary_10_1038_s41467_024_49921_7
crossref_primary_10_1016_j_atherosclerosis_2019_07_003
crossref_primary_10_1161_ATVBAHA_120_315300
crossref_primary_10_3390_ijms25063537
crossref_primary_10_1080_15592294_2020_1739797
crossref_primary_10_1186_s40478_024_01909_6
crossref_primary_10_1194_jlr_M090381
crossref_primary_10_1016_j_plipres_2017_09_001
crossref_primary_10_1186_s13059_024_03316_5
crossref_primary_10_1097_MOL_0000000000000855
crossref_primary_10_1161_ATVBAHA_118_312267
crossref_primary_10_37586_2686_8636_4_2024_335_341
crossref_primary_10_3389_fpubh_2022_923797
crossref_primary_10_1186_s12920_024_01905_8
crossref_primary_10_1097_FPC_0000000000000524
crossref_primary_10_1007_s11883_022_01016_8
crossref_primary_10_1016_j_tcm_2023_01_003
crossref_primary_10_1016_j_numecd_2021_02_011
crossref_primary_10_1016_j_atherosclerosis_2018_06_863
crossref_primary_10_1080_14737159_2024_2421497
crossref_primary_10_1016_j_atherosclerosis_2021_06_004
crossref_primary_10_23736_S0393_0564_25_00077_9
crossref_primary_10_1093_eurheartj_ehac361
crossref_primary_10_1161_CIRCGEN_119_002775
crossref_primary_10_1016_j_athoracsur_2025_01_013
crossref_primary_10_1042_BCJ20240037
crossref_primary_10_1016_j_atherosclerosissup_2019_08_044
crossref_primary_10_1038_s10038_021_00968_0
crossref_primary_10_1001_jamanetworkopen_2020_0129
crossref_primary_10_1038_s41467_018_04668_w
crossref_primary_10_1016_j_acvd_2024_07_061
crossref_primary_10_1080_10408363_2017_1415866
crossref_primary_10_1016_j_beem_2023_101746
crossref_primary_10_1161_CIRCULATIONAHA_119_044434
crossref_primary_10_1161_JAHA_123_033654
crossref_primary_10_1177_0300060520965353
crossref_primary_10_1016_j_pathol_2018_11_003
crossref_primary_10_1097_HCO_0000000000000721
crossref_primary_10_1038_s41598_025_07989_1
crossref_primary_10_1194_jlr_P091009
crossref_primary_10_1093_cvr_cvab136
crossref_primary_10_1016_j_plipres_2025_101343
crossref_primary_10_2174_1381612829666230601155001
crossref_primary_10_1016_j_jlr_2023_100336
crossref_primary_10_3390_ijms24010170
crossref_primary_10_3390_genes14061259
crossref_primary_10_1097_FJC_0000000000001160
crossref_primary_10_1016_j_atherosclerosis_2023_04_012
crossref_primary_10_1016_j_atherosclerosis_2022_04_013
crossref_primary_10_1016_j_numecd_2023_07_019
crossref_primary_10_1016_j_atherosclerosis_2025_119174
crossref_primary_10_1016_j_jacasi_2025_04_012
crossref_primary_10_1042_BSR20240403
crossref_primary_10_1016_j_acvd_2021_10_009
crossref_primary_10_1194_jlr_M094540
crossref_primary_10_3390_diagnostics15141809
crossref_primary_10_1016_j_artere_2024_07_008
crossref_primary_10_1016_j_jacbts_2025_04_012
crossref_primary_10_1097_MOL_0000000000000499
crossref_primary_10_1093_eurheartj_ehaf526
crossref_primary_10_1016_j_jacc_2019_10_019
crossref_primary_10_1080_14779072_2025_2564137
crossref_primary_10_1016_j_atherosclerosis_2022_04_003
crossref_primary_10_1016_j_atherosclerosis_2022_04_002
crossref_primary_10_1371_journal_pbio_2002907
crossref_primary_10_1016_j_canep_2023_102395
crossref_primary_10_3390_genes12070991
crossref_primary_10_1194_jlr_C079111
crossref_primary_10_1016_j_pcad_2023_07_006
crossref_primary_10_1016_j_phrs_2021_105812
crossref_primary_10_1038_s41598_022_10923_4
crossref_primary_10_1016_j_atherosclerosis_2022_04_008
crossref_primary_10_1080_17446651_2023_2293108
crossref_primary_10_1016_j_artere_2024_04_001
crossref_primary_10_1186_s13073_020_00771_0
crossref_primary_10_4330_wjc_v16_i6_329
crossref_primary_10_1016_j_cpcardiol_2024_102586
crossref_primary_10_1038_s41569_021_00613_5
crossref_primary_10_3389_fphys_2024_1395371
crossref_primary_10_1126_science_abg8289
crossref_primary_10_1161_JAHA_117_008461
crossref_primary_10_3390_ijms21134680
crossref_primary_10_1016_j_jacc_2021_05_037
crossref_primary_10_3390_biomedicines10081832
crossref_primary_10_1016_j_jacl_2020_05_002
crossref_primary_10_3390_jcm14092990
crossref_primary_10_1016_j_ebiom_2025_105562
crossref_primary_10_1093_clinchem_hvaa324
crossref_primary_10_1097_MOL_0000000000000753
crossref_primary_10_1111_joim_13338
crossref_primary_10_1016_j_jacl_2017_10_024
crossref_primary_10_1093_eurjpc_zwae371
crossref_primary_10_3390_biomedicines10020259
crossref_primary_10_1161_CIRCGEN_117_001696
crossref_primary_10_1161_ATV_0000000000000147
crossref_primary_10_1016_j_atherosclerosis_2021_05_001
crossref_primary_10_1111_joim_20027
crossref_primary_10_1161_ATVBAHA_119_313877
crossref_primary_10_1161_CIRCGEN_121_003489
crossref_primary_10_3389_fgene_2021_709555
crossref_primary_10_3390_ijerph20186721
crossref_primary_10_1371_journal_pone_0232073
crossref_primary_10_1161_ATVBAHA_118_310865
crossref_primary_10_1016_j_phrs_2023_106843
crossref_primary_10_1136_bmjopen_2019_030097
ContentType Journal Article
Copyright Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.
Copyright_xml – notice: Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1194/jlr.M076232
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Open Access Full Text
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1539-7262
EndPage 1844
ExternalDocumentID oai_doaj_org_article_403ae2f7fd6d4d4daf7d9b0aea676a23
28512139
Genre Meta-Analysis
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: U01 HL067900
– fundername: NHLBI NIH HHS
  grantid: U01 HL067902
– fundername: Austrian Science Fund FWF
  grantid: P 26660
– fundername: NHLBI NIH HHS
  grantid: U01 HL067894
– fundername: NHLBI NIH HHS
  grantid: U01 HL067895
– fundername: NHLBI NIH HHS
  grantid: U01 HL067897
– fundername: NHLBI NIH HHS
  grantid: U01 HL067901
– fundername: NHLBI NIH HHS
  grantid: U01 HL067899
– fundername: NHLBI NIH HHS
  grantid: U01 HL067893
– fundername: NHLBI NIH HHS
  grantid: U01 HL067896
GroupedDBID ---
-~X
.55
.GJ
0R~
0VX
18M
29K
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
AAEDW
AAFWJ
AALRI
AAXUO
AAYWO
ABCQX
ABOCM
ACCCW
ACGFO
ACKIV
ACNCT
ACPRK
ACVFH
ADBBV
ADCNI
ADVLN
AENEX
AEUPX
AEXQZ
AFFNX
AFOSN
AFPKN
AFPUW
AI.
AIGII
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BTFSW
C1A
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FDB
FRP
GROUPED_DOAJ
GX1
H13
HH5
HYE
H~9
J5H
KQ8
L7B
MVM
NPM
OK1
P2P
RHI
ROL
RPM
TBC
TR2
TWZ
VH1
W8F
WH7
WOQ
X7M
YHG
YKV
ZGI
ZXP
~KM
7X8
ID FETCH-LOGICAL-c521t-b85c3deae2bc7417ae182bca73979af34df703a88c3e6f1e8ebfc544303ce61a3
IEDL.DBID DOA
ISICitedReferencesCount 124
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000408912600010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1539-7262
0022-2275
IngestDate Fri Oct 03 12:47:53 EDT 2025
Wed Oct 01 12:49:38 EDT 2025
Mon Jul 21 05:50:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords coronary artery disease
epidemiology
genetics
Language English
License Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c521t-b85c3deae2bc7417ae182bca73979af34df703a88c3e6f1e8ebfc544303ce61a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/403ae2f7fd6d4d4daf7d9b0aea676a23
PMID 28512139
PQID 1899793923
PQPubID 23479
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_403ae2f7fd6d4d4daf7d9b0aea676a23
proquest_miscellaneous_1899793923
pubmed_primary_28512139
PublicationCentury 2000
PublicationDate 2017-09-01
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of lipid research
PublicationTitleAlternate J Lipid Res
PublicationYear 2017
Publisher Elsevier
Publisher_xml – name: Elsevier
References 28698209 - J Lipid Res. 2017 Sep;58(9):1731-1732. doi: 10.1194/jlr.C079111.
References_xml – reference: 28698209 - J Lipid Res. 2017 Sep;58(9):1731-1732. doi: 10.1194/jlr.C079111.
SSID ssj0014461
Score 2.5691626
SecondaryResourceType review_article
Snippet High lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for cardiovascular outcomes. Concentrations are strongly influenced by apo(a)...
SourceID doaj
proquest
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage 1834
SubjectTerms Animals
Apolipoproteins A - genetics
Apolipoproteins A - metabolism
coronary artery disease
epidemiology
genetics
Genome-Wide Association Study - methods
Humans
Lipoprotein(a) - genetics
Lipoprotein(a) - metabolism
Polymorphism, Single Nucleotide
Protein Isoforms - metabolism
Sex Characteristics
Title A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
URI https://www.ncbi.nlm.nih.gov/pubmed/28512139
https://www.proquest.com/docview/1899793923
https://doaj.org/article/403ae2f7fd6d4d4daf7d9b0aea676a23
Volume 58
WOSCitedRecordID wos000408912600010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bS-QwFA6uCLsv4mXXu0QQcR-ibXpJ-ziK4oMOgu4ysCzlJD2BitOR6Yziv_ck7bjug_gihT6E0IbzheT7cvkOY_tJamMwJhAyRBBxLjOhcx0Io0MFYaCN8ve4f1-qfj8bDPLrN6m-3Jmw1h64DdxxHESA0ipbpmVMD1hV0scAIVUpSO_zSaxnJqa6_QMSOeHMJ1xKlXQ380ixH9_dj4-uSL1Ll3HE-_S_Ty79JHO-xBY7dsh7bauW2RzWK2y1V5MyHj7zA-7Pa_qF8BX29XSWq22VTXvcma0OUTxVJXL4F3M-xAkI6KxHOBXcVw8j785Q1fwQfnLjLi7WnXtuw6G8m7olUE5sloPL4fB_9aoZOZ7b_Ln5-539Oj-7Pb0QXUIFYVzeAqGzxEQlUjwJg5jAQFIX2oBym3tgo7i0NABAlpkIUxtihtoaZ5AXRAbTEKIfbL4e1bjOOCoShjlmJkmBOEgOgSG2oVNNYU0iixvsxIW2eGg9MwrnYu0LCNuiw7b4CNsNtjcDpqCAuq0MqHE0bYqQZCKNLLmrs9Yi9vorSSRSErHd_IwmbLFv0k3k_lTZNpufjKe4wxbM46Rqxrvsixpku77r0bt_ffUCqGDhgg
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+genome-wide+association+meta-analysis+on+lipoprotein+%28a%29+concentrations+adjusted+for+apolipoprotein+%28a%29+isoforms%5BS%5D&rft.jtitle=Journal+of+lipid+research&rft.au=Salome+Mack&rft.au=Stefan+Coassin&rft.au=Rico+Rueedi&rft.au=Noha+A.+Yousri&rft.date=2017-09-01&rft.pub=Elsevier&rft.issn=0022-2275&rft.volume=58&rft.issue=9&rft.spage=1834&rft.epage=1844&rft_id=info:doi/10.1194%2Fjlr.M076232&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_403ae2f7fd6d4d4daf7d9b0aea676a23
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1539-7262&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1539-7262&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1539-7262&client=summon